COMMUNIQUÉS West-GlobeNewswire

AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
14/07/2026
BERWYN, Pa., July 14, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces it has been named as a Preferred Vendor [...]
Arizona Nonprofit Launches "Ultimate Road Trip" Fundraiser Inspiring Families to Make Memories While Funding Childhood Blindness Research
14/07/2026
Winner will receive a 2026 Thor Axis motorhome, a Ford Bronco Badlands, and $50,000 cash in one of the charity's largest travel adventure prize packages ever. GILBERT, Ariz., July 14, 2026 (GLOBE NEWSWIRE) -- What if [...]
Captain James A. Lovell Federal Health Care Center to Treat Post-Traumatic Stress With Virtual Reality Donated by Nonprofit SoldierStrong
14/07/2026
STAMFORD, Conn., July 14, 2026 (GLOBE NEWSWIRE) -- The Captain James A. Lovell Health Care Center in North Chicago, Illinois, is the country’s latest Department of Veterans Affairs facility to partner with national [...]
IBA – Regulated information
14/07/2026
July 14 th , 2026 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various [...]
Medicana Health Group Opens Belgrade Liaison Office to Strengthen Its Presence in the Balkans
14/07/2026
The new office in Serbia marks an important step in Medicana Health Group’s regional growth strategy and supports its expanding international healthcare network across Europe Photo: Opening ceremony of Medicana Health [...]
TAP Sleep Care Highlights Breakthrough Case Study on myTAP® Oral Appliance in Journal of Dental Sleep Medicine: Dramatic Two-Night Improvement in Treatment-Resistant OSA
14/07/2026
DALLAS, July 14, 2026 (GLOBE NEWSWIRE) -- TAP Sleep Care ® , a leader in innovative oral appliance therapy for snoring and obstructive sleep apnea (OSA), today announced the publication of a compelling case report [...]
React19 Applauds Introduction of the Vaccine Injury Compensation Modernization Act of 2026
14/07/2026
Bipartisan legislation marks the most significant effort in decades to restore fairness to America's vaccine injury compensation system WASHINGTON, July 14, 2026 (GLOBE NEWSWIRE) -- React19 today applauded the [...]
Cherry Hills Recovery Opens July 13, Bringing Specialized Residential Care for Female Executives to Colorado
14/07/2026
ENGLEWOOD, Colo., July 14, 2026 (GLOBE NEWSWIRE) -- Cherry Hills Recovery, a program of Ignitus Recovery, is proud to announce the opening of its premier women's residential behavioral health treatment center in [...]
IBA – Information Réglementée
14/07/2026
Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et [...]
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026
Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting TOKYO and CAMBRIDGE, Mass., July 14, 2026 [...]
Organic & Natural Health Association and India's SHEFEXIL Establish Strategic Partnership to Strengthen U.S.-India Supply Chain
14/07/2026
WASHINGTON, July 14, 2026 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association (Organic & Natural Health) and the Shellac & Forest Products Export Promotion Council (SHEFEXIL), an export promotion [...]
Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility
14/07/2026
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer
14/07/2026
Phase 1/2 trial of SOT109 in patients with advanced unresectable or metastatic colorectal cancer expected to commence in Q3 2026 PRAGUE and BASEL, Switzerland and BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- SOTIO Biotech [...]
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
14/07/2026
Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 Preclinical data for sutacimig in Factor VII deficiency (FVIID) [...]
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
14/07/2026
$13.75 million underwritten public offering with up to an additional $29.6 million in potential proceeds tied to the cash exercise in full of the milestone warrants issued in the offering IRVINE, Calif., July 14, 2026 ( [...]
Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor
14/07/2026
SYDNEY, AUSTRALIA, July 14, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a new [...]
Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%
14/07/2026
Through a series of investments over the past year, including an additional investment made in June 2026, Weinstein has built an ownership position of more than 30% as Pluri advances its longevity and U.S. [...]
Smile Doctors Outpaces First-Half Growth Plan, Nears 600 Locations Nationwide
14/07/2026
Entering its second decade, the nation's largest ortho-focused support organization posts double-digit first-half growth as new orthodontist affiliations, de novo expansion and accelerating adult demand continue to [...]
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access
14/07/2026
- Dr. Robert J. Kossmann has served as a prominent advocate for kidney disease patients in multiple roles including Executive Vice President and Chief Medical Officer for Fresenius Medical Care North America - - Dr. [...]

Pages